Current evidence supports vitamin D₃ as a safe, cost-effective, and promising adjuvant strategy in oncology; however, its routine clinical application requires validation through well-designed, large-scale randomized controlled trials to establish optimal dosing strategies, identify responsive patient populations, and...
S. Khan, Sumbul Saeed, Hajer N. Sheikh et al.· Molecular Biology Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.